NPs Basic Information

Name
Tetroquinone
Molecular Formula C6H4O6
IUPAC Name*
2,3,5,6-tetrahydroxycyclohexa-2,5-diene-1,4-dione
SMILES
C1(=C(C(=O)C(=C(C1=O)O)O)O)O
InChI
InChI=1S/C6H4O6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h7-8,11-12H
InChIKey
DGQOCLATAPFASR-UHFFFAOYSA-N
Synonyms
Tetrahydroxyquinone; tetroquinone; 319-89-1; 2,3,5,6-tetrahydroxycyclohexa-2,5-diene-1,4-dione; Tetrahydroxy-1,4-benzoquinone; Kelox; Tetrahydroxy-p-benzoquinone; Terasin; HPEK-1; Tetrahydroxy-p-quinone; Tetrahydroxy-1,4-quinone; Tetrahydroxyparabenzoquinone; Tetroquinona; Tetroquinonum; 2,5-Cyclohexadiene-1,4-dione, 2,3,5,6-tetrahydroxy-; 2,3,5,6-Tetrahydroxy-p-benzoquinone; NSC-112931; U7L4P6H0SU; NSC112931; NCGC00095043-01; p-Benzoquinone, 2,3,5,6-tetrahydroxy-; DSSTox_CID_25897; DSSTox_RID_81209; DSSTox_GSID_45897; Tetrahydroxy-1,4-benzoquinone;Tetrahydroxybenzoquinone; Tetrochinone; Tetrochinone [DCIT]; Tetrahydroxy-1,4-benzoquinone Hydrate; CAS-319-89-1; Tetroquinone [USAN:INN]; UNII-U7L4P6H0SU; Tetroquinonum [INN-Latin]; Tetroquinona [INN-Spanish]; Tetraoxychinon; 2,3,5,6-tetrahydroxy-1,4-benzoquinone; 4-benzoquinone; SR-05000002066; Tetrahydroxy-1; tetrahydroxy quinone; EINECS 206-275-5; NSC 112931; tetrahydroxybenzoquinone; Spectrum_001691; Prestwick0_000835; Prestwick1_000835; Prestwick2_000835; Prestwick3_000835; Spectrum2_000866; Spectrum3_000750; Spectrum4_000847; Spectrum5_001627; TETROQUINONE [MI]; Tetroquinone (USAN/INN); TETROQUINONE [INN]; TETROQUINONE [USAN]; BSPBio_000789; BSPBio_002340; KBioGR_001453; KBioSS_002171; DivK1c_000623; SCHEMBL167587; SPECTRUM1503330; SPBio_000911; SPBio_002710; 2,3,5,6-Tetrahydroxy-2,5-cyclohexadiene-1,4-dione; BPBio1_000869; SCHEMBL4657549; CHEMBL1329029; DTXSID9045897; HMS501P05; KBio1_000623; KBio2_002171; KBio2_004739; KBio2_007307; KBio3_001560; CHEBI:137472; NINDS_000623; HMS1922A16; HMS2093E07; Pharmakon1600-01503330; 2,5,6-Tetrahydroxy-p-benzoquinone; HY-B1106; YEA33416; ZINC1665742; Tox21_111400; CCG-39742; MFCD00001597; NSC758457; p-Benzoquinone,3,5,6-tetrahydroxy-; STL453704; AKOS006228209; Tox21_111400_1; CS-4703; DS-3819; NSC-758457; 2,4-dione, 2,3,5,6-tetrahydroxy-; IDI1_000623; NCGC00095043-02; NCGC00095043-03; NCGC00095043-04; NCGC00095043-07; 2,3,5,6-Tetrahydroxybenzo-1,4-quinone; AC-18203; 2,3,5,6-tetrahydroxy-[1,4]benzoquinone; SBI-0051815.P002; DB-068561; tetrahydroxycyclohexa-2,5-diene-1,4-dione; 2,3,5,6-Tetrahydroxybenzo-1,4-quinone #; FT-0656093; T1090; D06096; F17741; AB00052347_04; A821088; J-018590; Q3546866; SR-05000002066-1; 2,3,5,6-Tetrahydroxy-2,5-cyclohexadien-1,4-dione
CAS 319-89-1
PubChem CID 5424
ChEMBL ID CHEMBL1329029
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Organic oxygen compounds
      • Class: Organooxygen compounds
        • Subclass: Carbonyl compounds
          • Direct Parent: P-benzoquinones

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 172.09 ALogp: -0.6
HBD: 4 HBA: 6
Rotatable Bonds: 0 Lipinski's rule of five: Accepted
Polar Surface Area: 115.0 Aromatic Rings: 1
Heavy Atoms: 12 QED Weighted: 0.388

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -5.346 MDCK Permeability: 0.00018584
Pgp-inhibitor: 0 Pgp-substrate: 0.072
Human Intestinal Absorption (HIA): 0.015 20% Bioavailability (F20%): 0.004
30% Bioavailability (F30%): 0.042

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.402 Plasma Protein Binding (PPB): 80.46%
Volume Distribution (VD): 0.43 Fu: 12.43%

ADMET: Metabolism

CYP1A2-inhibitor: 0.02 CYP1A2-substrate: 0.056
CYP2C19-inhibitor: 0.081 CYP2C19-substrate: 0.052
CYP2C9-inhibitor: 0.071 CYP2C9-substrate: 0.357
CYP2D6-inhibitor: 0.008 CYP2D6-substrate: 0.117
CYP3A4-inhibitor: 0.009 CYP3A4-substrate: 0.012

ADMET: Excretion

Clearance (CL): 1.099 Half-life (T1/2): 0.234

ADMET: Toxicity

hERG Blockers: 0.012 Human Hepatotoxicity (H-HT): 0.499
Drug-inuced Liver Injury (DILI): 0.437 AMES Toxicity: 0.094
Rat Oral Acute Toxicity: 0.095 Maximum Recommended Daily Dose: 0.001
Skin Sensitization: 0.745 Carcinogencity: 0.003
Eye Corrosion: 0.25 Eye Irritation: 0.979
Respiratory Toxicity: 0.923
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC003525 0.432 D07AHW 0.245
ENC000670 0.400 D04AIT 0.222
ENC003505 0.387 D0K8KX 0.216
ENC001362 0.333 D07EXH 0.200
ENC000934 0.321 D0R9WP 0.188
ENC000335 0.303 D0H1AR 0.188
ENC000822 0.297 D08NQZ 0.188
ENC001058 0.279 D0S0LZ 0.188
ENC004924 0.278 D0U3YB 0.184
ENC002929 0.275 D00KRE 0.184
*Note: the compound similarity was calculated by RDKIT.